Announced
Financials
Tags
Acquisition
Single Bidder
Canada
Domestic
Pending
Majority
cannabis
Medical Supplies
Friendly
Public
Synopsis
Ayr Strategies, an expanding vertically integrated, US multi-state cannabis operator, agreed to acquire Liberty Health Sciences, a manufacturer and distributor of medical cannabis, for c.$372m. "With the support from Ayr, Liberty dispensary openings across the state will accelerate and product expansion will be enhanced. Shareholders will benefit not only from the strong growth in the Florida market, but also from the growth in other key states. Our employees will have exposure to new opportunities and career paths. We are delighted to become part of the AYR family of companies," George Gremse, Liberty Interim Chief Executive Officer and Director. On February 23, 2021, Liberty Health Sciences shareholders approved the acquisition.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.